Merran P. Macpherson
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antibiotics Pharmacokinetics and Efficacy 5
-
- Antibiotic Resistance in Bacteria 2
- Co-authors
- Shampa Das (5 shared papers)James Gardner Wright (4 shared papers)Todd A. Riccobene (3 shared papers)Paul A. Newell (2 shared papers)Timothy J. Carrothers (2 shared papers)Ronald Andrew Seaton (1 shared paper)Elizabeth B. Lamont (1 shared paper)Zsuzsanna Pápai (1 shared paper)
- Journals
- European Journal of Clinical Pharmacology (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Antimicrobial Agents and Chemotherapy (1 paper)Clinical and Translational Science (1 paper)Expert Opinion on Drug Metabolism & Toxicology (1 paper)
- Partner nations
- United KingdomUnited StatesBelgium
In The Last Decade
Merran P. Macpherson
13 papers receiving 377 citations
Peers
Comparison fields: 5 of 54
- Molecular Medicine 122
- Applied Microbiology and Biotechnology 27
- Pharmacology 134
- Epidemiology 81
- Oncology 60
Countries citing papers authored by Merran P. Macpherson
This map shows the geographic impact of Merran P. Macpherson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Merran P. Macpherson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Merran P. Macpherson more than expected).
Fields of papers citing papers by Merran P. Macpherson
This network shows the impact of papers produced by Merran P. Macpherson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Merran P. Macpherson. The network helps show where Merran P. Macpherson may publish in the future.
Co-authors
The 25 scholars most cited alongside Merran P. Macpherson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 81 | |
| 2 | 2010 | 76 | |
| 3 | 2009 | 45 | |
| 4 | 2018 | 42 | |
| 5 | 2018 | 29 | |
| 6 | 2011 | 27 | |
| 7 | 2024 | 26 | |
| 8 | 2022 | 21 | |
| 9 | 2020 | 17 | |
| 10 | 2005 | 9 | |
| 11 | 2015 | 7 | |
| 12 | 2023 | 5 | |
| 13 | 2024 | 1 |
About Merran P. Macpherson
Merran P. Macpherson is a scholar working on Pharmacology, Molecular Medicine, Clinical Biochemistry, Epidemiology and Psychiatry and Mental health, having authored 13 papers that have together received 386 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (5 papers), Antibiotic Resistance in Bacteria (2 papers), Pneumonia and Respiratory Infections (2 papers), Antimicrobial Resistance in Staphylococcus (1 paper), Bacterial Identification and Susceptibility Testing (1 paper), Biosimilars and Bioanalytical Methods (1 paper), Pharmaceutical studies and practices (1 paper) and Lipoproteins and Cardiovascular Health (1 paper). The work is most often cited by research in Molecular Medicine (122 citations), Applied Microbiology and Biotechnology (27 citations), Pharmacology (134 citations), Epidemiology (81 citations) and Oncology (60 citations). Merran P. Macpherson has collaborated with scholars based in United Kingdom, United States and Belgium. Frequent co-authors include Shampa Das, James Gardner Wright, Todd A. Riccobene, Paul A. Newell, Timothy J. Carrothers, Ronald Andrew Seaton, Elizabeth B. Lamont, Zsuzsanna Pápai, Kathleen Pritchard and Fátima Cardoso. Their work appears in journals such as European Journal of Clinical Pharmacology, Cancer Chemotherapy and Pharmacology, Antimicrobial Agents and Chemotherapy, Clinical and Translational Science and Expert Opinion on Drug Metabolism & Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.